PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsEsophageal and gastric varices
MeSH D004932 - esophageal and gastric varices
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D004935:Esophageal diseases
$
Success rate
D006975:Portal hypertension
0 Companies
0 Drugs
Success rate
D004932: 
Esophageal and gastric varices
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaPropranolol Propranolol  1987-10-07   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1988-12-01   
MylanPropranolol Propranolol  1985-11-19   
Sodium tetradecyl sulfate Sotradecol  2004-11-12   
Rising PharmaceuticalsPropranolol Propranolol  2007-02-15   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1987-03-04   
SandozPropranolol Propranolol  1988-07-05   
WyethPropranolol Inderal  1982-01-01   
Propranolol, Hydrochlorothiazide Inderide  1985-07-03   
Propranolol, Hydrochlorothiazide Inderide-  1982-01-01   
Merck & CoPropranolol Propranolol  1985-08-06   
Zydus TherapeuticsPropranolol Propranolol  2011-03-25   
Warner ChilcottPropranolol Propranolol  1986-09-15   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1988-01-26   
Chartwell PharmaceuticalsPropranolol Propranolol  1986-06-13   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1987-08-26   
Impax LaboratoriesPropranolol Propranolol  1988-04-06   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
100%
2/2
Phase 3
46%
6/13
Approved: 2Overall Success rate: 46%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use